Search

everythinglearnresearchcommunity

for

Search:↓

Deucravacitinib did not significantly improve hair regrowth in alopecia areata patients.

Divalproex sodium significantly improved headaches in two-thirds of patients.

A woman with severe hair loss saw significant hair regrowth after adding platelet-rich plasma injections to her treatment with tofacitinib.

The document concludes that ERBB2 mutations are common in extramammary Paget disease and may respond to systemic treatments like cancer immunotherapy.

New treatments are making advanced prostate cancer management more complex but also more hopeful.

The treatment improved hair growth and thickness in patients with hair loss, even 10 months after therapy without additional products.

The treatment is safe and shows promise for metastatic breast cancer.

Retinoic acid is effective for treating eruptive vellus hair cysts.

Topical antibiotics successfully treated a rare scalp condition in an elderly man with vitiligo.

The study suggests a link between varicella-zoster virus and segmental vitiligo, with evidence of the virus disrupting skin pigment cells.

ATR04-484 ointment shows promise for treating skin issues from cancer therapies.

Tadalafil and Finasteride may help treat aggressive melanoma.

CAP1/Prss8 does not activate PAR2 or inhibit PN-1.

Most patients with anal Pemphigus Vulgaris had repeated episodes but fully recovered with treatment, without long-term problems.

Proxalutamide improved blood markers related to inflammation, immune response, and clotting in COVID-19 patients, potentially reducing hospitalizations.

Applying a tretinoin cream can remove hair plugs and treat trichostasis spinulosa.

Topical aprepitant reduces skin rash and hair loss caused by cancer treatment.

The substances improved hair regrowth and protected hair cells in humans and mice.

Beer yeast vesicles may improve hair follicle health.

Personalized treatment based on detailed tumor analysis successfully managed and reduced the patient's aggressive hair follicle cancer.

Finasteride may help reduce COVID-19 infection by altering a key gene.

A new device, IVL-PPF Microsphere®, was created to deliver a hair loss drug for up to 3 months with one injection, potentially replacing daily pills.

Oral paclitaxel plus encequidar improved tumor response and caused less neuropathy but more serious infections than intravenous paclitaxel.

Ixekizumab has known and some unexpected side effects.

Sacituzumab govitecan is effective but has side effects like hair loss and diarrhea in treating metastatic triple-negative breast cancer.

A patient's skin rash did not affect the area where a previous viral rash was healing, suggesting a rare immune response.

The new fluoroquinolone effectively fights certain bacteria.

Tofacitinib effectively regrows hair in alopecia universalis triggered by a virus.